Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone
FDA Approves Opioid Treatment
Nonopioid Medication May Be as Effective as Opioids for Chronic Pain
FDA Sets Stricter Requirements for Immediate-Release Opioids to Prevent Misuse & Abuse
Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More
CVS to Pay $5 Million to Resolve U.S. Drug Probe
Opana ER Pulled from U.S. Market
FDA Responds to New Drug Application for Baricitinib
